CPHI vs VRTX · rev $4.1M vs P/E 30, rev $12.00B
China Pharma Holdings Inc (CPHI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CPHI currently screens at market cap $29.0M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CPHI and VRTX stock pages for the full models.
Not investment advice.